Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

AVEO Pharmaceuticals Granted U.S. Patent #11504365: Use of tivozanib to treat subjects with refractory cancer

Author: Charles Gross | November 22, 2022 08:57am
https://www.scribd.com/document/609450380/Aveo-Patent

Posted In: AVEO